首页> 外文期刊>Muscle and Nerve >Hyperlactacidemia as a risk factor for intensive care unit-acquired weakness in critically ill adult patients
【24h】

Hyperlactacidemia as a risk factor for intensive care unit-acquired weakness in critically ill adult patients

机译:Hyperlactacidemia as a risk factor for intensive care unit-acquired weakness in critically ill adult patients

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction/Aims Intensive care unit-acquired weakness (ICUAW) is a severe neuromuscular complication of critical illness. Serum lactate is a useful biomarker in critically ill patients. The relationship between serum lactate level and ICUAW remains controversial. This study evaluated whether hyperlactacidemia (lactate level >2 mmol/L) was an independent risk factor for ICUAW in critically ill adult patients.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号